Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
anti glp 1 antibody Anti-GLP-1 (7-36) Antibody, CT amide-reactive metabolism support Electrolyte+ Flavour:Blackcurrant Burst Suitable for IHC FDA just approved orforglipron
FDA just approved orforglipron (Foundayo), Eli Lilly's oral GLP-1 receptor agonist for obesity.
Summary: GLP-1 agonists work by activating GLP-1 receptors throughout the body, triggering glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
metabolism support
Electrolyte+ Flavour:Blackcurrant Burst
Occasionally, FSAs may ask for the Letter to confirm the eligibility of your purchase
Suitable for IHC
US$ 20.97
US$ 29.34
US$ 22.97
US$ 26.59
US$ 29.32
US$ 23.20
US$ 20.33
